REFRACTORY ANEMIA
Clinical trials for REFRACTORY ANEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ANEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo targets Hard-to-Treat blood cancers
Disease control CompletedThis early-phase trial tested a mix of a cancer vaccine, chemotherapy, and immunotherapy in 8 people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) with low blast counts. The goal was to see if the combination is safe and helps the immune system fight cancer …
Matched conditions: REFRACTORY ANEMIA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 09:31 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses low-dose chemo and radiation before a donor stem cell infusion, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer…
Matched conditions: REFRACTORY ANEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 09:31 UTC